Kinin B2 receptor-mediated bradykinin internalization and metalloendopeptidase EP24.15-dependent intracellular bradykinin degradation

Journal of Pharmacology and Experimental Therapeutics

Volumn 326, Issue 1, 2008, Pages 24-32

  Sandén, Caroline ^a   Enquist, Johan ^a,c   Bengtson, Sara H ^b   Herwald, Heiko ^b   Leeb Lundberg, L M Fredrik ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BRADYKININ; CALCIUM ION; METALLOPROTEINASE; MOLECULAR MARKER; PHOSPHATIDYLINOSITIDE; THIMET OLIGOPEPTIDASE; BRADYKININ B2 RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL MEMBRANE; CELL STIMULATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; EMBRYO; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENZYME MECHANISM; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN LOCALIZATION; CELL LINE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; INTRACELLULAR FLUID; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; BRADYKININ; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTRACELLULAR FLUID; METALLOENDOPEPTIDASES; PROTEIN BINDING; RECEPTOR, BRADYKININ B2;

EID: 45749091327     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.136911     Document Type: Article

References (37)

1. Bengtson SH, Phagoo SB, Norrby-Teglund A, Påhlman L, Mörgelin M, Zuraw BL, Leeb-Lundberg LMF, and Herwald H (2006) Kinin receptor expression during Staphylococcus aureus infection. Blood 108:2055-2063.
2. Carreño FR, Goñi CN, Castro LM, and Ferro ES (2005) 14-3-3 Epsilon modulates the stimulated secretion of endopeptidase 24.15. J Neurochem 93:10-25.
3. Chen Z, Deddish PA, Minshall RD, Becker RP, Erdös EG, Tan F (2006) Human ACE and bradykinin B2 receptors form a complex at the plasma membrane. FASEB J 20:2261-2270.
4. Crack PJ, Wu TJ, Cummins PM, Ferro ES, Tullai JW, Glucksman MJ, and Roberts JL (1999) The association of metalloendopeptidase EC 3.4.24.15 at the extracellular surface of the AtT-20 cell plasma membrane. Brain Res 835:113-124.
5. Da Silva A, Dhuy J, Waeldele F, Bertrand C, and Landry Y (1992) Endopeptidase 24.15 modulates bradykinin-induced contraction in guinea-pig trachea. Eur J Pharmacol 212:97-99.
6. Dauch P, Vincent J-P, and Checler F (1991) Specific inhibition of endopeptidase 24.16 by dipeptides. Eur J Biochem 202:269-276.
7. de Weerd WFC and Leeb-Lundberg LMF (1997) Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells. J Biol Chem 272:17858-17866.
8. Dendorfer A, Vordermark D, and Dominiak P (1997) Degradation of bradykinin by bovine tracheal epithelium and isolated epithelial cells. Br J Pharmacol 120:121-129.
9. 1 receptor endocytosis. Mol Pharmacol 71:494-507.
10. Fathy D, Mathis SA, Leeb T, and Leeb-Lundberg LMF (1998) A single position in the third transmembrane domains of the human B1 and B2 bradykinin receptors is adjacent to and discriminates between the C-terminal residues of subtype-selective ligands. J Biol Chem 273:12210-12218.
11. Ferro ES, Tullai JW, Glucksman MJ, and Roberts JL (1999) Secretion of metallopeptidase 24.15 (EC 3.24.15). DNA Cell Biol 18:781-789.
12. Ferro ES, Hyslop S, and Camargo ACM (2004) Intracellular peptides as putative natural regulators of protein interactions. J Neurochem 91:769-777.
13. Haasemann M, Cartaud J, Müller-Esterl W, and Dunia I (1998) Agonist-induced redistribution of bradykinin B2 receptor in caveolae. J Cell Sci 111:917-928.
14. Jeske NA, Glucksman MJ, and Roberts JL (2003) EP24.15 is associated with lipid rafts. J Neurosci Res 74:468-473.
15. Jeske NA, Glucksman MJ, and Roberts JL (2004) Metalloendopeptidase EC3.4.24.15 is constitutively released from the exofacial leaflet of lipid rafts in GT1-7 cells. J Neurochem 90:819-828.
16. Jeske NA, Berg KA, Cousins JC, Ferro ES, Clarke WP, Glucksman MJ, and Roberts JL (2006) Modulation of bradykinin signaling by EP24.15 and EP24.16 in cultured trigeminal ganglia. J Neurochem 97:13-21.
17. Kang DS and Leeb-Lundberg LMF (2002) Negative and positive regulatory epitopes in the C-terminal domains of the human B1 and B2 bradykinin receptor subtypes determine receptor coupling efficacy to G(q/11)-mediated phospholipase Cβ activity. Mol Pharmacol 62:281-288.
18. Kim SI, Pabon A, Swanson TA, and Glucksman MJ (2003) Regulation of cell-surface major histocompatibility complex class I expression by the endopeptidase EC3.4.24.15 (thimet oligopeptidase). Biochem J 375:111-120.
19. Lamb ME, Zhang C, Shea T, Kyle DJ, and Leeb-Lundberg LMF (2002) Human B1 and B2 bradykinin receptors and their agonists target caveolae-related lipid rafts to different degrees in HEK293 cells. Biochemistry 41:14340-14347.
20. Leeb-Lundberg LMF and Mathis SA (1990) Guanine nucleotide regulation of B2 kinin receptor binding: time-dependent formation of a guanine nucleotide-sensitive receptor state from which [3H]bradykinin dissociates slowly. J Biol Chem 265:9621-9627.
21. Leeb-Lundberg LMF, Marceau F, Müller-Esterl F, Pettibone DJ, and Zuraw BL (2005) International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57:27-77.
22. Leeb T, Mathis SA, and Leeb-Lundberg LMF (1997) The sixth transmembrane domains of the human B1 and B2 bradykinin receptors are structurally compatible and involved in discriminating between subtype-selective agonists. J Biol Chem 272:311-317.
23. Marceau F, Hess F, and Bachvarov D (1998) The B1 receptor for kinins. Pharmacol Rev 50:357-386.
24. Munoz CM and Leeb-Lundberg LMF (1992) Receptor-mediated internalization of bradykinin. DDT1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradative pathways. J Biol Chem 267:303-309.
25. Norman MU, Lew RA, Smith AI, and Hickey MJ (2003) Metalloendopeptidases EC 3.4.24.15/16 regulate bradykinin activity in the cerebral microvasculature. Am J Physiol Heart Circ Physiol 284:H1942-H1948.
26. Oliveira V, Garrido PAG, Rodrigues CC, Colquhoun A, Castro LM, Almeida PC, Shida CS, Juliano MA, Juliano L, Camargo ACM, et al. (2005) Calcium modulates endopeptidase 24.15 (EC 3.3.24.15) membrane association, secondary structure and substrate specificity. FEBS J 272:2978-2992.
27. Orlowski M, Reznik S, Ayala J, and Pierotti AR (1989) Endopeptidase 24.15 from rat testes. Isolation of the enzyme and its specificity toward synthetic and natural peptidase, including enkephalin-containing peptides. Biochem J 261:951-958.
28. Portaro FCV, Gomes MD, Cabrera A, Fernandes BL, Silva CL, Ferro ES, Juliano L, and de Camargo ACM (1999) Thimet oligopeptidase and the stability of MHC class I epitopes in macrophage cytosol. Biochem Biophys Res Commun 255:596-601.
29. Schriefer JA and Molineaux CJ (1993) Modulatory effect of endopeptidase inhibitors on bradykinin-induced contraction of rat uterus. J Pharmacol Exp Ther 266:700-706.
30. Shivakumar BR, Wang Z, Hammond TG, and Harriset RC (2005) EP24.15 interacts with the angiotensin II type I receptor and bradykinin B2 receptor. Cell Biochem Funct 23:195-204.
31. Shrimpton CN, Smith AI, and Lew RA (2002) Soluble metalloendopeptidases and neuroendocrine signaling. Endocr Rev 23:647-664.
32. Silva CL, Portaro FCV, Bonato VLD, de Camargo ACM, and Ferro ES (1999) Thimet oligopeptidase (EC 3.4.24.15), a novel protein on the route of MHC class I antigen presentation. Biochem Biophys Res Commun 255:591-595.
33. Skidgel RA (1992) Bradykinin-degrading enzymes: structure, function, distribution, and potential roles in cardiovascular pharmacology. J Cardiovasc Pharmacol 20:S4-S9.
34. Smith AI, Lew RA, Shrimpton CN, Evans RG, and Abbenante G (2000) A novel stable inhibitor of endopeptidases EC 3.4.24.15 and 3.4.24.16 potentiates bradykinin-induced hypotension. Hypertension 35:626-630.
35. Tropea MM, Munoz CM, and Leeb-Lundberg LMF (1992) Bradykinin binding to B2 kinin receptors and stimulation of phosphoinositide turnover and arachidonic acid release in primary cultures of cells from the late pregnant myometrium. Can J Physiol Pharmacol 70:1360-1371.
36. Vietinghoff G and Paegelow I (2000) Degradation of bradykinin by peritoneal and alveolar macrophages of the guinea pig. Peptides 21:1249-1255.
37. Whistler JL, Enquist J, Marley A, Fong J, Gladher F, Tsuruda P, Murray SR, and von Zastrow M (2002) Modulation of postendocytic sorting of G protein-coupled receptors. Science 297:615-620.